MARKET

TYRA

TYRA

Tyra Biosciences, Inc.
NASDAQ
10.24
-0.07
-0.68%
After Hours: 10.24 0 0.00% 16:05 03/26 EDT
OPEN
10.29
PREV CLOSE
10.31
HIGH
10.56
LOW
10.10
VOLUME
116.98K
TURNOVER
--
52 WEEK HIGH
29.60
52 WEEK LOW
9.93
MARKET CAP
518.17M
P/E (TTM)
-6.3745
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TYRA last week (0317-0321)?
Weekly Report · 2d ago
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga · 03/17 12:58
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Benzinga · 03/17 11:40
Weekly Report: what happened at TYRA last week (0310-0314)?
Weekly Report · 03/17 09:04
Weekly Report: what happened at TYRA last week (0303-0307)?
Weekly Report · 03/10 09:04
Weekly Report: what happened at TYRA last week (0224-0228)?
Weekly Report · 03/03 09:04
Tyra Biosciences: FGFR1/2 Driven AE Data Spooked The Market
Seeking Alpha · 03/01 08:14
Weekly Report: what happened at TYRA last week (0217-0221)?
Weekly Report · 02/24 09:04
More
About TYRA
Tyra Biosciences, Inc. is a clinical-stage biotechnology company. It is focused on developing precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations to cause acquired resistance to existing therapies. Its initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. Its lead product candidate, TYRA-300, is an investigational, oral, FGFR3-selective inhibitor being evaluated in an international, multi-center, open label Phase 1 clinical study, SURF301. Its second oncology product candidate, TYRA-200, is an investigational, oral, FGFR1/2/3 inhibitor with potency against activating FGFR2 gene alterations, and clinically important molecular brake and gatekeeper resistance mutations.

Webull offers Tyra Biosciences Inc stock information, including NASDAQ: TYRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TYRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TYRA stock methods without spending real money on the virtual paper trading platform.